The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index; 35 of the 68 sources its claims cite were checked for support.
Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms
Open accessAbstract
The serum level of iron in humans is tightly controlled by the action of the hormone hepcidin on the iron efflux transporter ferroportin. Hepcidin regulates iron absorption and recycling by inducing the internalization and degradation of ferroportin 1. Aberrant ferroportin activity can lead to diseases of iron overload, such as haemochromatosis, or iron limitation anaemias 2. Here we determine cryogenic electron microscopy structures of ferroportin in lipid nanodiscs, both in the apo state and in complex with hepcidin and the iron mimetic cobalt. These structures and accompanying molecular dynamics simulations identify two metal-binding sites within the N and C domains of ferroportin. Hepcidin binds ferroportin in an outward-open conformation and completely occludes the iron efflux pathway to inhibit transport. The carboxy terminus of hepcidin directly contacts the divalent metal in the ferroportin C domain. Hepcidin binding to ferroportin is coupled to iron binding, with an 80-fold increase in hepcidin affinity in the presence of iron. These results suggest a model for hepcidin regulation of ferroportin, in which only ferroportin molecules loaded with iron are targeted for degradation. More broadly, our structural and functional insights may enable more targeted manipulation of the hepcidin-ferroportin axis in disorders of iron homeostasis.
Overview
CoChat Summary
TL;DR
The paper reports cryo-EM structures of human ferroportin in lipid nanodiscs in the apo state and bound to Co²⁺ and hepcidin, revealing two metal-binding sites and an outward-open hepcidin-bound conformation that occludes the iron efflux pathway. It further shows that hepcidin binding is coupled to iron, with an approximately 80-fold increase in hepcidin affinity in the presence of Fe²⁺.
Key findings
- Cryo-EM structures were determined for apo FPN–Fab45D8 at 3.2 Å and Co²⁺–hepcidin–FPN–Fab45D8 at 2.5 Å. Two metal-binding sites were identified: an N-domain site coordinated by D39 and H43, and a C-domain site coordinated by C326, H507, water-mediated D325/T320 backbone contacts, and the carboxy terminus of hepcidin.
- Hepcidin binds in the central cavity of outward-open FPN and acts as a molecular cork, occluding the iron efflux pathway. Internally added hepcidin inhibited Co²⁺ transport, whereas externally added hepcidin had minimal effect; β-mercaptoethanol rescued transport of a reconstituted hepcidin–FPN complex.
- RhoG-hepcidin bound nanodisc-reconstituted FPN with an apparent K_D of 210 nM; with 10 μM FeCl₂, affinity increased to 2.5 nM, an almost 80-fold change. CoCl₂ also increased affinity to 7.7 nM, while C-domain mutants D325N, C326S, and H507R bound hepcidin weakly even with 50 μM CoCl₂.
- In all six molecular dynamics simulations with Fe²⁺ initially in bulk solvent, Fe²⁺ spontaneously bound the C-domain site near D325, D504, and H507, with an average time to bind of 71 ns; iron binding reduced TM7b and D325 mobility.
Methods
- Human FPN was expressed and purified, reconstituted into NW9 lipid nanodiscs with Fab45D8, and imaged by cryo-EM for apo and Co²⁺/hepcidin-bound complexes; Fab45D8 was also solved by X-ray crystallography at 2.1 Å.
- Metal transport was measured using a liposome-based calcein quenching assay with FeCl₂ and CoCl₂, and hepcidin binding was measured by fluorescence polarization using rhodamine-green-labeled hepcidin at position 17.
- All-atom molecular dynamics simulations used the outward-open apo FPN structure under three conditions—iron-absent, iron-bound, and iron-in-bulk-solvent—with six independent simulations per condition, each run for at least 2.2 μs.
Limitations
- The paper states that no statistical methods were used to predetermine sample size, experiments were not randomized, and investigators were not blinded during experiments or outcome assessment.
- The text notes that FPN extracellular loop 5 (ECL5) remains unresolved, likely due to conformational flexibility; Fab45D8 decreased both V_max and K_m of CoCl₂ transport, suggesting it prefers a subset of FPN conformations, though it did not inhibit transitions required for transport.
- Evident from the text: Co²⁺ was used as a surrogate for Fe²⁺ because Fe²⁺ is readily oxidized, the calcein assay primarily measures forward transport, and unresolved loops between TM6–TM7 and TM9–TM10 were not modeled in the molecular dynamics simulations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
23 Valid · 0 Not valid · 11 Not checked · 141 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“FPN also enables iron recycling from hepatocytes and macrophages 5 .”
What the sources say
- Partly supportedcites [5] Knutson, M. D., Oukka, M., Koss, L. M., Aydemir, F. & Wessling-Resnick, M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc. Natl Acad. Sci. USA 102, 1324–1328 (2005). sourceExperimental — accuracy not yet measured
The Abstract reports that FPN1 enables iron recycling from macrophages after erythrophagocytosis. The Discussion says hepatocytes express high levels of FPN1, but does not establish that FPN1 enables iron recycling from hepatocytes. (LLM, conf=0.89)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Mutation of D39 to alanine or glutamate abolishes iron transport 22,27 , which was previously ascribed to disruption of a putative calcium binding site within the N domain of FPN 27 .”
What the sources say
- Not checked — no full text of the sourcecites [22] Bonaccorsi di Patti, M. C. et al. A structural model of human ferroportin and of its iron binding site. FEBS J. 281, 2851–2860 (2014). source
- Partly supportedcites [27] Deshpande, C. N. et al. Calcium is an essential cofactor for metal efflux by the ferroportin transporter family. Nat. Commun. 9, 3075 (2018). sourceExperimental — accuracy not yet measured
The Results section on mutagenesis of putative Ca²⁺-coordinating residues reports that D39E abolished iron-transport activity in human ferroportin. It does not report that changing D39 to alanine (D39A) abolished transport; a search for D39A found no such result in our copy. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Ferroportin shares structural similarity with a previously characterized bacterial homolog, the bbFPN transporter 26 (Extended Data Fig. 6).”
What the sources say
- Supportedcites [26] Taniguchi, R. et al. Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin. Nat. Commun. 6, 8545 (2015). source
The Results section identifies BbFPN as a putative bacterial homologue of human ferroportin and reports 24% sequence identity and 40% similarity. It also describes a human ferroportin structural model built from the BbFPN structure, supporting the attributed structural similarity. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Mutation of several residues within the intracellular gate leads to FPN loss of function in ferroportin disease, highlighting the importance of the gate in coordinating the conformational steps necessary for iron efflux 19,28 .”
What the sources say
- Supportedcites [19] Vlasveld, L. T. et al. Twenty years of ferroportin disease: a review or an update of published clinical, biochemical, molecular, and functional features. Pharmaceuticals 12, 132 (2019). source
Section 4.3 (page not supplied) states that, with two exceptions, residues altered in loss-of-function variants are at intracellular sites, especially structures forming the gate responsible for iron transport. It also explains that alterations there may disrupt gate formation or iron egress. (LLM, conf=0.90)
- Supportedcites [28] Guellec, J. et al. Molecular model of the ferroportin intracellular gate and implications for the human iron transport cycle and hemochromatosis type 4A. FASEB J. 33, 14625–14635 (2019). source
The Discussion identifies seven intracellular-gate residues affected by missense mutations associated with ferroportin disease and reports that several substitutions reduce FPN1 iron export or cause mislocalization. The in-vitro evaluation also found that mutations at several gating residues impaired iron export. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several FPN mutations decrease hepcidin binding to FPN, including N144H/D/T 34-36 , C326S/F/Y 13,29-31 , Y333H 37 , Y501C 7,38 , D504N 7,39 and H507R 32 .”
What the sources say
- Not checked — no full text of the sourcecites [34] Wallace, D. F., Clark, R. M., Harley, H. A. J. & Subramaniam, V. N. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. J. Hepatol. 40, 710–713 (2004). source
- Not checked — no full text of the sourcecites [35] Njajou, O. T. et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat. Genet. 28, 213–214 (2001). source
- Partly supportedcites [36] Arden, K. E. et al. A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut 52, 1215–1217 (2003). sourceExperimental — accuracy not yet measured
The Results and Discussion identify N144T in a Solomon Islands patient and discuss the previously reported N144H mutation. The paper does not report decreased hepcidin binding for either mutation, nor does it address N144D or the other listed mutations. Its mention of hepcidin concerns mutations in the hepcidin gene, not binding to ferroportin. (LLM, conf=0.84)
- Partly supportedcites [13] Drakesmith, H. et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106, 1092–1097 (2005). sourceExperimental — accuracy not yet measured
The section on hepcidin-mediated surface expression reports that N144D and N144H are partially resistant to hepcidin, while C326Y is resistant to hepcidin-mediated down-regulation. It does not measure decreased hepcidin binding. The Discussion says C326S was not tested; our copy does not establish the claimed effect for the other listed variants. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [29] Sham, R. L. et al. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol. Dis. 34, 157–161 (2005). source
- Partly supportedcites [30] Schimanski, L. M. et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105, 4096–4102 (2005). sourceExperimental — accuracy not yet measured
The Discussion proposes that N144H and N144D might prevent FPN from interacting with hepcidin, but presents this as a possibility, not a measured decrease in binding. The Introduction lists N144T as a disease-associated mutation without linking it to hepcidin binding. In the citing sentence, this source is attached to the N144H/D/T group, not the later mutations. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [31] Viprakasit, V. et al. Molecular diagnosis of the first ferroportin mutation (C326y) in the Far East causing a dominant form of inherited iron overload. Blood 104, 3204 (2004). source
- Not checked — no full text of the sourcecites [37] Zhang, W. et al. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: a recurrent cause of haemochromatosis in China. Liver Int. 39, 1120–1127 (2019). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
95 more claims · 5 with their cited sources checked
Create a free account to see all 175 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 41
- It may state two separate claims as one. 37
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent structural analyses revealed that the binding between hepcidin and FPN is coupled to iron binding, with iron significantly increasing the binding affinity, thus explaining why only iron-loaded FPN molecules are targeted for degradation.10,53”
From RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a nanodisc membrane model, hepcidin is seen to bind to the C-lobe of ferroportin (Figure 3), with the highly variable hepcidin loop largely extracellular, and the relatively conserved C- and N-termini of hepcidin deeply buried in the central cavity.”
From Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis (2021) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The model also revealed an important unexpected feature, the indication that the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine, utilizes an iron atom to coordinate hepcidin binding [14].”
From Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis (2021) · cites this paper as [14]
Experimental — accuracy not yet measuredIn the citing paper
“the hormone hepcidin (encoded by the HAMP1 gene) controls cellular iron homeostasis and plasma iron concentrations by binding to FPN, inducing its internalization and subsequent degradation.9,10”
From RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation (2021) · cites this paper as [10]
Citations
Cites
VMD: visual molecular dynamics
Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Ryckaert, J.-P., Ciccotti, G., & Berendsen, H. J. C. (1977) · Journal of Computational Physics · doi:10.1016/0021-9991(77)90098-5 · Cited by 21,239
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E., Armache, J.-P., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,777
Self-citationPTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data
Roe, D. R., & Cheatham, T. E. (2013) · Journal of Chemical Theory and Computation · doi:10.1021/ct400341p · Cited by 7,382
Cited by
Pasricha, S.-R., Tye-Din, J., Muckenthaler, M. U., & Swinkels, D. W. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32594-0 · Cited by 1,069
Mechanisms controlling cellular and systemic iron homeostasis
Galy, B., Conrad, M., & Muckenthaler, M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00648-1 · Cited by 785
Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Nemeth, E., & Ganz, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126493 · Cited by 540
“The model also revealed an important unexpected feature, the indication that the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine, utilizes an iron atom to coordinate hepcidin binding [14].”
BackgroundStructures and General Transport Mechanisms by the Major Facilitator Superfamily (MFS)
Drew, D., North, R. A., Nagarathinam, K., & Tanabe, M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00983 · Cited by 465
Hepcidin and Iron in Health and Disease
Nemeth, E., & Ganz, T. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-032816 · Cited by 457
Metadata
- Authors
- Billesbølle, C. B., Azumaya, C. M., Kretsch, R. C., Powers, A. S., Gonen, S., Schneider, S., Arvedson, T., Dror, R. O., Cheng, Y., & Manglik, A.
- Affiliations
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Howard Hughes Medical Institute (US)
- Goethe University Frankfurt (DE)
- Amgen (United States) (US)
- Corresponding author
- Cheng, Yifan
- Manglik, Aashish
- ORCID
- Venue
- Nature
- Published
- 2020-08-19
- Volume
- 586
- Issue
- 7831
- Pages
- 807-811
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7906036
- OpenAlex
- W3070670479
- Cited by
- 344
- References
- 91
- Citations by year
- 2026: 41 · 2025: 76 · 2024: 63 · 2023: 69 · 2022: 48 · 2021: 38 · 2020: 9
- FWCI
- 25.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (1s10od021741-01, DP5OD023048, 1s10od020054-01)
- National Institute of General Medical Sciences (T32GM120007, T32GM008293, R01GM098672)
- National Institute of Allergy and Infectious Diseases (P50AI150476)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- hepcidin, ferroportin, iron homeostasis, iron efflux, cobalt binding, metal binding sites, hemochromatosis, iron overload, iron deficiency anemia, lipid nanodiscs, cryo-EM structure, molecular dynamics simulation
- MeSH terms
- Protein Domains, Ferroportin, Apoproteins, Binding Sites, Cobalt, Homeostasis, Humans, Iron, Cryoelectron Microscopy, Cation Transport Proteins, Molecular Dynamics Simulation, Proteolysis, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. https://app.cochat.ai/papers/10.1038/s41586-020-2668-z
- The paper
- Billesbølle, C. B., Azumaya, C. M., Kretsch, R. C., Powers, A. S., Gonen, S., Schneider, S., Arvedson, T., Dror, R. O., Cheng, Y., & Manglik, A. (2020). Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature. https://doi.org/10.1038/s41586-020-2668-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.